Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

ClinicalTrials.gov ID: NCT04000009

Public ClinicalTrials.gov record NCT04000009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Open-Label Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the safety and tolerability of long-term pimavanserin treatment in subjects with major depressive disorder and inadequate response to antidepressant treatment.

Study identification

NCT ID
NCT04000009
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
235 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2019
Primary completion
Feb 21, 2021
Completion
Feb 21, 2021
Last update posted
Apr 4, 2022

2019 – 2021

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
CNS Network Garden Grove California 90806
Behavioral Research Specialists Glendale California 91206
Irvine Clinical Research Irvine California 92614
Synergy San Diego Lemon Grove California 91945
Pacific Research Partners, LLC Oakland California 94607
NRC Research Institute Orange California 92868
MCB Clinical Research centers, LLC Colorado Springs Colorado 80910
Clinical Neuroscience Solutions ( CNS Healthcare)-Jacksonville Jacksonville Florida 32256
Meridien Research Maitland Florida 32751
Florida Research Center, Inc. Miami Florida 33174
CNS Health Care (Orlando) Orlando Florida 32801
Emory University School of Medicine Atlanta Georgia 30322
Synexus Clinical Research Atlanta Georgia 30328
Great Lakes Clinical Trials Chicago Illinois 60640
Capstone Clinical Research Libertyville Illinois 60048
Collective Medical Research, LLC Prairie Village Kansas 66208
Adams Clinical Watertown Massachusetts 02472
Integrative Clinical Trials Brooklyn New York 11229
Social Psychiatry Research Institute (SPRI) Brooklyn New York 11235
Department of Psychiatry, Icahn School of Medicine at Mount Sinai New York New York 10029
The Medical Research Network, LLC New York New York 10128
Finger Lakes Clinical Research Rochester New York 14618
Charak Clinical Research Center Garfield Heights Ohio 44125
Summit Research Network (Oregon) Inc. Portland Oregon 97210
University of Pennsylvania Philadelphia Pennsylvania 19104
Coastal Carolina Research Center Mt. Pleasant South Carolina 26464
Clinical Neuroscience Solutions CNS Healthcare Memphis Tennessee 38119
Research Strategies of Memphis, LLC Memphis Tennessee 38119
Future Search Trials of Dallas Dallas Texas 75231
Baylor College of Medicine Houston Texas 77030
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Grayline Research Center Wichita Falls Texas 76309
IPC Research Waukesha Wisconsin 53188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04000009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2022 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04000009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →